Abstract
Purpose
High-normal thyrotropin (TSH) is related to reduced insulin sensitivity and may contribute to glycemic disorders in diabetes. We investigated the relationship between normal serum TSH levels and glycemic variability in euthyroid type 2 diabetic patients.
Methods
A total of 432 newly diagnosed type 2 diabetic patients with euthyroid function and normal serum TSH levels were recruited between March 2013 and February 2017. Insulin sensitivity was evaluated by the Matsuda index (ISIMatsuda) following a 75-g oral glucose tolerance test. Multiple glycemic variability indices, including the mean amplitude of glycemic excursions (MAGE), mean of daily differences (MODD), and standard deviation of glucose (SD), were calculated from glucose data obtained with a continuous glucose monitoring system. Average glucose accessed by 24-h mean glucose (24-h MG) was also calculated.
Results
A normal serum TSH level was positively correlated with MAGE, MODD, SD, and 24-h MG (r = 0.206, 0.178, 0.186, and 0.132, respectively, p < 0.01). After adjusting for somatometric parameters, lipid profiles, ISIMatsuda, and HbA1c via multiple linear regression analysis, mean differences [B(95% CI)] in MAGE, MODD, SD, and 24-h MG between the patients in the lowest and highest quartiles of TSH levels were 0.128(0.031, 0.226), 0.085(0.022, 0.148), 0.039(0.001, 0.078), and 0.002(−0.264, 0.267) mmol/L, respectively. High-normal TSH was independently associated with MAGE, MODD, and SD, but not 24-h MG.
Conclusions
High-normal serum TSH is a significant additional risk factor for increased glycemic variability in type 2 diabetic patients.
Similar content being viewed by others
Abbreviations
- TSH:
-
Thyrotropin
- FT3:
-
Free triiodothyronine
- FT4:
-
Free thyroxine
- TPO-Ab:
-
Thyroperoxidase antibody
- ISIMatsuda :
-
Insulin sensitivity index recommended by Matsuda
- MAGE:
-
Mean amplitude of glycemic excursions
- MODD:
-
Mean of daily differences
- SD:
-
Standard deviation of glucose
- 24-h MG:
-
24-h mean glucose
- BMI:
-
Body mass index
- SBP:
-
Systolic blood pressure
- DBP:
-
Diastolic blood pressure
- TC:
-
Total cholesterol
- TG:
-
Triglyceride
- HDLC:
-
High-density lipoprotein cholesterol
- LDLC:
-
Low-density lipoprotein cholesterol
- HbA1c:
-
Glycosylated hemoglobin A1c
References
O. Sarfo-Kantanka, F.S. Sarfo, E.O. Ansah, E. Yorke, J. Akpalu, B.C. Nkum, B. Eghan, Frequency and determinants of thyroid autoimmunity in Ghanaian type 2 diabetes patients: a case-control study. BMC Endocr. Disord. 17(1), 2 (2017). https://doi.org/10.1186/s12902-016-0152-4
M.A. Pisarev, Interrelationships between the pancreas and the thyroid. Curr. Opin. Endocrinol. Diabetes Obes. 17(5), 437–439 (2010). https://doi.org/10.1097/MED.0b013e32833e0750
C. Wang, The relationship between type 2 diabetes mellitus and related thyroid diseases. J. Diabetes Res. 2013, 390534 (2013). https://doi.org/10.1155/2013/390534
A. Roos, S.J. Bakker, T.P. Links, R.O. Gans, B.H. Wolffenbuttel, Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects. J. Clin. Endocrinol. Metab. 92(2), 491–496 (2007). https://doi.org/10.1210/jc.2006-1718
L.J. van Tienhoven-Wind, R.P. Dullaart, Low-normal thyroid function and novel cardiometabolic biomarkers. Nutrients 7(2), 1352–1377 (2015). https://doi.org/10.3390/nu7021352
A. Giandalia, G.T. Russo, E.L. Romeo, A. Alibrandi, P. Villari, A.A. Mirto, G. Armentano, S. Benvenga, D. Cucinotta, Influence of high-normal serum TSH levels on major cardiovascular risk factors and Visceral Adiposity Index in euthyroid type 2 diabetic subjects. Endocrine 47(1), 152–160 (2014). https://doi.org/10.1007/s12020-013-0137-2
L. Chaker, S. Ligthart, T.I. Korevaar, A. Hofman, O.H. Franco, R.P. Peeters, A. Dehghan, Thyroid function and risk of type 2 diabetes: a population-based prospective cohort study. BMC Med. 14(1), 150 (2016). https://doi.org/10.1186/s12916-016-0693-4
M. Kasuga, Insulin resistance and pancreatic beta cell failure. J. Clin. Invest. 116(7), 1756–1760 (2006). https://doi.org/10.1172/jci29189
L. Monnier, C. Colette, D.R. Owens, Integrating glycaemic variability in the glycaemic disorders of type 2 diabetes: a move towards a unified glucose tetrad concept. Diabetes Metab. Res. Rev. 25(5), 393–402 (2009). https://doi.org/10.1002/dmrr.962
American Diabetes Association, Diagnosis and classification of diabetes mellitus. Diabetes Care 34(Suppl 1), S62–S69 (2011). https://doi.org/10.2337/dc11-S062
M. Matsuda, R.A. DeFronzo, Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22(9), 1462–1470 (1999)
N.R. Hill, N.S. Oliver, P. Choudhary, J.C. Levy, P. Hindmarsh, D.R. Matthews, Normal reference range for mean tissue glucose and glycemic variability derived from continuous glucose monitoring for subjects without diabetes in different ethnic groups. Diabetes Technol. Ther. 13(9), 921–928 (2011). https://doi.org/10.1089/dia.2010.0247
Y.M. Wang, L.H. Zhao, J.B. Su, H.F. Qiao, X.H. Wang, F. Xu, T. Chen, J.F. Chen, G. Wu, X.Q. Wang, Glycemic variability in normal glucose tolerance women with the previous gestational diabetes mellitus. Diabetol. Metab. Syndr. 7, 82 (2015). https://doi.org/10.1186/s13098-015-0077-5
L. Monnier, E. Mas, C. Ginet, F. Michel, L. Villon, J.P. Cristol, C. Colette, Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. J. Am. Med. Assoc. 295(14), 1681–1687 (2006). https://doi.org/10.1001/jama.295.14.1681
M. Ohara, T. Fukui, M. Ouchi, K. Watanabe, T. Suzuki, S. Yamamoto, T. Yamamoto, T. Hayashi, K. Oba, T. Hirano, Relationship between daily and day-to-day glycemic variability and increased oxidative stress in type 2 diabetes. Diabetes Res. Clin. Pract. 122, 62–70 (2016). https://doi.org/10.1016/j.diabres.2016.09.025
K. Torimoto, Y. Okada, H. Mori, Y. Tanaka, Relationship between fluctuations in glucose levels measured by continuous glucose monitoring and vascular endothelial dysfunction in type 2 diabetes mellitus. Cardiovasc. Diabetol. 12, 1 (2013). https://doi.org/10.1186/1475-2840-12-1
W. Xu, Y. Zhu, X. Yang, H. Deng, J. Yan, S. Lin, H. Yang, H. Chen, J. Weng, Glycemic variability is an important risk factor for cardiovascular autonomic neuropathy in newly diagnosed type 2 diabetic patients. Int. J. Cardiol. 215, 263–268 (2016). https://doi.org/10.1016/j.ijcard.2016.04.078
G. Su, S. Mi, H. Tao, Z. Li, H. Yang, H. Zheng, Y. Zhou, C. Ma, Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes. Cardiovasc. Diabetol. 10, 19 (2011). https://doi.org/10.1186/1475-2840-10-19
M.A. van Baak, 24-hour glucose profiles on diets varying in protein content and glycemic index. Nutrients 6(8), 3050–3061 (2014). https://doi.org/10.3390/nu6083050
A.M. Marker, A.E. Noser, M.A. Clements, S.R. Patton, Shared responsibility for type 1 diabetes care is associated with glycemic variability and risk of glycemic excursions in youth. J. Pediatr. Psychol. 43(1), 61–71 (2018). https://doi.org/10.1093/jpepsy/jsx081
C.M. Ma, F.Z. Yin, R. Wang, C.M. Qin, B. Liu, D.H. Lou, Q. Lu, Glycemic variability in abdominally obese men with normal glucose tolerance as assessed by continuous glucose monitoring system. Obesity 19(8), 1616–1622 (2011). https://doi.org/10.1038/oby.2011.5
S.V. Madhu, S.K. Muduli, R. Avasthi, Abnormal glycemic profiles by CGMS in obese first-degree relatives of type 2 diabetes mellitus patients. Diabetes Technol. Ther. 15(6), 461–465 (2013). https://doi.org/10.1089/dia.2012.0333
S.A. Brown, B. Jiang, M. McElwee-Malloy, C. Wakeman, M.D. Breton, Fluctuations of hyperglycemia and insulin sensitivity are linked to menstrual cycle phases in women with T1D. J. Diabetes Sci. Technol. 9(6), 1192–1199 (2015). https://doi.org/10.1177/1932296815608400
L. Monnier, C. Colette, S. Dejager, D. Owens, Magnitude of the dawn phenomenon and its impact on the overall glucose exposure in type 2 diabetes: is this of concern? Diabetes Care 36(12), 4057–4062 (2013). https://doi.org/10.2337/dc12-2127
K. Torimoto, Y. Okada, T. Arao, H. Mori, S. Yamamoto, M. Narisawa, A. Kurozumi, Y. Tanaka, Glucose variability before and after treatment of a patient with Graves’ disease complicated by diabetes mellitus: assessment by continuous glucose monitoring. Endocr. J. 61(4), 321–328 (2014)
C.K. Kramer, H. Choi, B. Zinman, R. Retnakaran, Glycemic variability in patients with early type 2 diabetes: the impact of improvement in beta-cell function. Diabetes Care 37(4), 1116–1123 (2014). https://doi.org/10.2337/dc13-2591
J.M. Fernandez-Real, A. Lopez-Bermejo, A. Castro, R. Casamitjana, W. Ricart, Thyroid function is intrinsically linked to insulin sensitivity and endothelium-dependent vasodilation in healthy euthyroid subjects. J. Clin. Endocrinol. Metab. 91(9), 3337–3343 (2006)
E.H. van den Berg, L.J. van Tienhoven-Wind, M. Amini, T.C. Schreuder, K.N. Faber, H. Blokzijl, R.P. Dullaart, Higher free triiodothyronine is associated with non-alcoholic fatty liver disease in euthyroid subjects: the Lifelines Cohort Study. Metabolism 67, 62–71 (2017). https://doi.org/10.1016/j.metabol.2016.11.002
G.L. Roef, E.R. Rietzschel, C.M. Van Daele, Y.E. Taes, M.L. De Buyzere, T.C. Gillebert, J.M. Kaufman, Triiodothyronine and free thyroxine levels are differentially associated with metabolic profile and adiposity-related cardiovascular risk markers in euthyroid middle-aged subjects. Thyroid 24(2), 223–231 (2014). https://doi.org/10.1089/thy.2013.0314
N. Takamura, A. Akilzhanova, N. Hayashida, K. Kadota, H. Yamasaki, T. Usa, M. Nakazato, T. Maeda, Y. Ozono, K. Aoyagi, Thyroid function is associated with carotid intima-media thickness in euthyroid subjects. Atherosclerosis 204(2), e77–e81 (2009). https://doi.org/10.1016/j.atherosclerosis.2008.09.022
I. Lambrinoudaki, E. Armeni, D. Rizos, G. Georgiopoulos, M. Kazani, A. Alexandrou, E. Deligeoroglou, A. Livada, C. Psychas, M. Creatsa, G. Bouboulis, M. Alevizaki, K. Stamatelopoulos, High normal thyroid-stimulating hormone is associated with arterial stiffness in healthy postmenopausal women. J. Hypertens. 30(3), 592–599 (2012). https://doi.org/10.1097/HJH.0b013e32834f5076
H. Li, Y. Cui, Y. Zhu, H. Yan, W. Xu, Association of high normal HbA1c and TSH levels with the risk of CHD: a 10-year cohort study and SVM analysis. Sci. Rep. 7, 45406 (2017). https://doi.org/10.1038/srep45406
J.E. Jun, J.H. Jee, J.C. Bae, S.M. Jin, K.Y. Hur, M.K. Lee, T.H. Kim, S.W. Kim, J.H. Kim, Association between changes in thyroid hormones and incident type 2 diabetes: a seven-year longitudinal study. Thyroid 27(1), 29–38 (2017). https://doi.org/10.1089/thy.2016.0171
J.E. Jun, S.M. Jin, J.H. Jee, J.C. Bae, K.Y. Hur, M.K. Lee, S.W. Kim, J.H. Kim, TSH increment and the risk of incident type 2 diabetes mellitus in euthyroid subjects. Endocrine 55(3), 944–953 (2017). https://doi.org/10.1007/s12020-016-1221-1
G. Bellastella, M.I. Maiorino, L. Scappaticcio, O. Casciano, M. Petrizzo, M. Caputo, V.A. Paglionico, D. Giugliano, K. Esposito, TSH oscillations in young patients with type 1 diabetes may be due to glycemic variability. J. Endocrinol. Invest. 41(4), 389–393 (2018). https://doi.org/10.1007/s40618-017-0752-5
T. Farasat, A.M. Cheema, M.N. Khan, Hyperinsulinemia and insulin resistance is associated with low T(3)/T(4) ratio in pre diabetic euthyroid Pakistani subjects. J. Diabetes Complicat. 26(6), 522–525 (2012). https://doi.org/10.1016/j.jdiacomp.2012.05.017
A. Javed, P.B. Balagopal, A. Vella, P.R. Fischer, F. Piccinini, C. Dalla Man, C. Cobelli, P.D. Giesler, J.M. Laugen, S. Kumar, Association between thyrotropin levels and insulin sensitivity in euthyroid obese adolescents. Thyroid 25(5), 478–484 (2015). https://doi.org/10.1089/thy.2015.0005
B.O. Asvold, L.J. Vatten, K. Midthjell, T. Bjoro, Serum TSH within the reference range as a predictor of future hypothyroidism and hyperthyroidism: 11-year follow-up of the HUNT Study in Norway. J. Clin. Endocrinol. Metab. 97(1), 93–99 (2012). https://doi.org/10.1210/jc.2011-1724
S.A. Chubb, W.A. Davis, T.M. Davis, Interactions among thyroid function, insulin sensitivity, and serum lipid concentrations: the Fremantle diabetes study. J. Clin. Endocrinol. Metab. 90(9), 5317–5320 (2005)
C. Menendez, R. Baldelli, J.P. Camina, B. Escudero, R. Peino, C. Dieguez, F.F. Casanueva, TSH stimulates leptin secretion by a direct effect on adipocytes. J. Endocrinol. 176(1), 7–12 (2003)
G. Fernandez-Formoso, S. Perez-Sieira, D. Gonzalez-Touceda, C. Dieguez, S. Tovar, Leptin, 20 years of searching for glucose homeostasis. Life Sci. 140, 4–9 (2015). https://doi.org/10.1016/j.lfs.2015.02.008
L. Marroqui, A. Gonzalez, P. Neco, E. Caballero-Garrido, E. Vieira, C. Ripoll, A. Nadal, I. Quesada, Role of leptin in the pancreatic beta-cell: effects and signaling pathways. J. Mol. Endocrinol. 49(1), R9–R17 (2012). https://doi.org/10.1530/jme-12-0025
Funding
The study was supported by the Medical Research Projects of Nantong Technology Bureau (HS2012028, MS22015065) and the Medical Research Project of Health and Family Planning Commission of Jiangsu (QNRC2016408).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This study conformed to the guidelines of the Declaration of Helsinki, and the study procedures were reviewed and approved by the Medical Research Ethics Committee of Second Affiliated Hospital of Nantong University.
Informed consent
Each patient agreed to participate in the study and signed the informed consent form.
Additional information
These authors contributed equally: Jian-Bin Su, Li-Hua Zhao.
Rights and permissions
About this article
Cite this article
Su, JB., Zhao, LH., Zhang, XL. et al. High-normal serum thyrotropin levels and increased glycemic variability in type 2 diabetic patients. Endocrine 61, 68–75 (2018). https://doi.org/10.1007/s12020-018-1591-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-018-1591-7